Public Policy
RSV Surge Raises Concern About Winter Virus Crisis More
Briefing
Insights provides context and perspective about key pharmacy trends and issues
Insights offers context and perspective about key pharmacy and health care topics.
Public Policy
In the wake of the Supreme Court decision on Rutledge vs. PCMA, states have introduced legislation threatening ERISA pre-emption for employer-sponsored health plans. More
Briefing
Public Policy
ACA Returns to Court
The California vs. Texas case before the U.S. Supreme Court could help determine the future of the Affordable Care Act (ACA), and could lead to one of several different results. More
Commentary
Public Policy
If ERISA pre-emption is not upheld for self-funded ERISA plans using PBMs to administer prescription drug benefits, we believe the implications may create unsustainable complexity and cost... More
Commentary
Public Policy
With a slate of bills trying to tackle rising drug prices, CVS Health advocates for those that could help increase competition and lower drug prices; others may limit private sector choice... More
Commentary
Public Policy
Our perspective offered to Congress on solutions and policies that can help bring escalating drug prices under control. More
Commentary
Public Policy
Solutions such as POS rebates and $0 copay drug lists can lower costs for plans and consumers, while a one-size-fits-all approach could lead to unintended consequences, and higher costs. More
Briefing
Public Policy
Proposed HHS rule would eliminate rebates PBMs negotiate for Part D plans and MCOs, and may eventually affect all plans. Manufacturers would retain 15% of rebates currently negotiated and... More
Briefing
Public Policy
As health care costs continue to rise and demand for primary care providers outpaces supply, pharmacists are increasingly on the front lines of care utilizing their clinical skills to help... More
Commentary